嗅觉丰富干预对老年骨科手术患者围术期神经认知障碍的影响:多中心随机对照试验研究方案
该多中心随机对照试验将纳入686例65岁及以上择期全麻骨科手术(预计至少2小时)患者,1:1随机接受嗅觉丰富或假干预,主要结局为术后谵妄发生率(3D-CAM评估),并评估延迟神经认知恢复和术后神经认知障碍等。
要点
- 嗅觉丰富组从术前1天至术后3天住院期间每日2次、每次30分钟暴露于4种气味,假干预组使用无味物质。
- 主要结局为术后第1、2、3天采用3D-CAM评估的术后谵妄发生率。
- 次要结局包括基线、术后21天和6个月神经心理测试评估的延迟神经认知恢复和术后神经认知障碍发生率。
核心结论
- 这是首个评估嗅觉丰富对老年骨科手术患者围术期神经认知障碍疗效的临床试验,填补了围术期神经认知障碍治疗证据的重要空白。
研究设计与样本
- 多中心、假干预对照、评估者盲法随机对照试验,计划纳入686例65岁及以上择期全麻骨科手术(预计至少2小时)患者,1:1随机分组。
主要发现
- 嗅觉丰富组从术前1天开始至术后3天住院期间每日2次、每次30分钟暴露于4种不同气味;假干预组按相同方案使用无味物质。
- 主要结局为术后第1、2、3天采用3D-CAM评估的术后谵妄发生率。
- 次要结局为基线、术后21天和6个月神经心理测试评估的延迟神经认知恢复和术后神经认知障碍发生率。
- 探索性结局包括CAM-S评估的谵妄严重程度、神经心理测试评估的延迟神经认知恢复和术后神经认知障碍严重程度、日常生活活动能力评估、血浆Tau-PT217水平和嗅觉功能。
- 试验已在ClinicalTrial.gov注册(NCT06488807),注册日期2024年6月15日;预计2025年3月开始,主要完成日期预计为2027年12月31日。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neurocognitive disorders are prevalent among older surgical patients, yet their underlying mechanisms and effective interventions remain largely unknown. Studies in rodents and patients suggest a connection between olfactory impairment and perioperative neurocognitive disorder (PND). Previous work in mice demonstrates that anesthesia and surgery can lead to both olfactory impairment and cognitive deficits. Olfactory enrichment, which is also referred to as olfactory training (i.e., daily exposure to multiple odorants), may prove helpful. For example, olfactory enrichment appears to reduce PND-like behaviors in mice, possibly by mitigating anesthesia- and surgery-induced reductions in olfactory receptor neurons. Additionally, olfactory enrichment increases the volume and size of olfactory-related brain regions, such as the olfactory bulb and hippocampus, as well as changes in functional connectivity in non-surgical adults. Despite promising findings in mice, it remains unknown whether olfactory training reduces PND in surgical patients. We therefore propose a randomized clinical trial. METHODS AND ANALYSIS: This sham-controlled assessor-blind randomized controlled trial will enroll 686 patients aged 65 and older who are scheduled for orthopedic Surgery expected to last at least 2h under general anesthesia. Participants will be randomized 1:1 to olfactory enrichment or sham treatment. Those assigned to the olfactory enrichment group will receive twice-daily 30-min sessions involving four distinct odors, beginning on 1 day before surgery and continuing for three postoperative days during hospitalization. Patients assigned to sham treatment will follow the same schedule, but with odorless substances in the scent dispenser. The primary outcome is the incidence of postoperative delirium, assessed using the 3-min diagnostic interview for CAM-defined delirium (3D-CAM) on postoperative days 1, 2, and 3. Secondary outcomes include the incidence of delayed neurocognitive recovery and postoperative neurocognitive disorder, evaluated through cognitive function assessments using neuropsychological tests at baseline, 21 days, and 6 months after the anesthesia/surgery. Exploratory outcomes include the severity of delirium measured by the CAM-severity (CAM-S) tools, the severity of delayed neurocognitive recovery and postoperative neurocognitive disorder assessed through neuropsychological tests, evaluations of activities of daily living, plasma Tau-PT217 levels, and olfactory function. DISCUSSION: This is the first clinical trial to evaluate the efficacy of olfactory enrichment in geriatric patients undergoing orthopedic surgery, filling an important gap in the treatment evidence for PND. TRIAL REGISTRATION: The trail has been registered in ClinicalTrial.gov with the Trial Registration Number of NCT06488807. Date of registration in the primary registry: June 15, 2024. The study is anticipated to start in March 2025. The anticipated primary completion date is December 31, 2027.
引用
- Mei X, Wang J, Ni Z, et al. Effects of olfactory enrichment on perioperative neurocognitive disorders in elderly patients undergoing orthopedic surgery: a study protocol of a multi-center randomized controlled trial. Trials. 2025. PMID: 41013688. doi:10.1186/s13063-025-09109-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。